Boston Scientific CorporationBSXNYSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+29.6%
5Y CAGR+45.9%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+29.6%/yr
vs +1.2%/yr prior
5Y CAGR
+45.9%/yr
Recent deceleration
Acceleration
+28.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
6.6x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $3.97B | +50.7% |
| 2024 | $2.63B | +20.8% |
| 2023 | $2.18B | +19.6% |
| 2022 | $1.82B | -5.1% |
| 2021 | $1.92B | +219.8% |
| 2020 | $601.00M | -64.9% |
| 2019 | $1.71B | -1.4% |
| 2018 | $1.74B | +13.9% |
| 2017 | $1.52B | +23.4% |
| 2016 | $1.24B | - |